Are patents an efficient and internationally fair means of funding research & development for new medicines?

In Denis Gordon Arnold (ed.), Ethics and the Business of Biomedicine. Cambridge University Press. pp. 62 (2009)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
Funding, objectivity and the socialization of medical research.James Robert Brown - 2002 - Science and Engineering Ethics 8 (3):295--308.
Industry, innovation and social values.Dr Harvey E. Bale Jr - 2005 - Science and Engineering Ethics 11 (1):31-40.
Surgical patents and patients — the ethical dilemmas.Tadeusz Tołłoczko - 2005 - Science and Engineering Ethics 11 (1):61-69.
Responsibilities for Global Health: The Efficiency of the Health Impact Fund?V. Paivansalo - 2009 - Public Health Ethics 2 (1):100-104.
Ethical issues in funding orphan drug research and development.C. A. Gericke - 2005 - Journal of Medical Ethics 31 (3):164-168.
The gap between law and ethics in human embryonic stem cell research: Overcoming the effect of U.s. Federal policy on research advances and public benefit.Patrick L. Taylor - 2005 - Science and Engineering Ethics 11 (4):589-616.
Non traditional R &.David Russell & Lloyd Fell - unknown
Inventions, patents and commercial development from governmentally financed research in Great Britain: The origins of the National Research Development Corporation. [REVIEW]S. T. Keith - 1981 - Minerva 19 (1):92-122.
Funding the frontier – the Human Frontier Science Program.Martin Reddington - 2010 - Bioessays 32 (10):842-844.
Ethics and the funding of research and development at universities.Raymond E. Spier - 1998 - Science and Engineering Ethics 4 (3):375-384.
Dveloping a Nomatively Grounded Research Agenda for Fair Trade Examining the Case of Canada. [REVIEW]Darryl Reed, Bob Thomson, Ian Hussey & Jean-Frédéric LeMay - 2010 - Journal of Business Ethics 92 (2):151 - 179.
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.

Analytics

Added to PP
2014-01-27

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references